Literature DB >> 10531255

T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts.

A Demissie1, P Ravn, J Olobo, T M Doherty, T Eguale, M Geletu, W Hailu, P Andersen, S Britton.   

Abstract

We examined the immune responses of patients with active pulmonary tuberculosis (TB) and their healthy household contacts to short-term culture filtrate (ST-CF) of Mycobacterium tuberculosis or molecular mass fractions derived from it. Our goal was to identify fractions strongly recognized by donors and differences among the donor groups of possible relevance for vaccine development. The study population consisted of 65 human immunodeficiency virus-negative donors from the Hossana Regional Hospital, Hossana, Ethiopia. Peripheral blood leukocytes from the donors were stimulated with different antigens and immune responses were determined. Household contacts produced significantly higher levels of gamma interferon (IFN-gamma) than the TB patients in response to antigens present in ST-CF and the 10 narrow-molecular-mass fractions. A similar difference in leukocyte proliferative responses to the antigens between the two groups was also found. In general, while all fractions stimulated immune responses, the highest activity was seen with the low-molecular-mass fractions, which include well-defined TB antigens such as ESAT-6. Leukocytes from contacts of TB patients with severe disease produced higher levels of antigen-specific IFN-gamma than those from contacts of patients with minimal disease. Both groups of contacts exhibited higher cell-mediated responses than the patients themselves. The enhanced immune response of healthy contacts, especially those of patients with severe disease, to secreted mycobacterial antigens is suggestive of an early stage of infection by M. tuberculosis, which could in time result in overt disease or containment of the infection. This possibility is currently being investigated by follow-up studies of the household contacts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531255      PMCID: PMC96981     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  The BCG story: lessons from the past and implications for the future.

Authors:  P E Fine
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

2.  Clinical correlates of interferon gamma production in patients with tuberculosis.

Authors:  A Sodhi; J Gong; C Silva; D Qian; P F Barnes
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

3.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

4.  Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle.

Authors:  J M Pollock; P Andersen
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.

Authors:  I Flesch; S H Kaufmann
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

7.  Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.

Authors:  P G Pal; M A Horwitz
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Human immune response to Mycobacterium tuberculosis antigens.

Authors:  D V Havlir; R S Wallis; W H Boom; T M Daniel; K Chervenak; J J Ellner
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Proteins released from Mycobacterium tuberculosis during growth.

Authors:  P Andersen; D Askgaard; L Ljungqvist; J Bennedsen; I Heron
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

10.  Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.

Authors:  I M Orme
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more
  19 in total

1.  CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.

Authors:  Gillian L Beamer; Joshua Cyktor; David K Flaherty; Paul C Stromberg; Bridget Carruthers; Joanne Turner
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

2.  Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis.

Authors:  D N Wedlock; B Vesosky; M A Skinner; G W de Lisle; I M Orme; B M Buddle
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Exosomes and other extracellular vesicles in host-pathogen interactions.

Authors:  Jeffrey S Schorey; Yong Cheng; Prachi P Singh; Victoria L Smith
Journal:  EMBO Rep       Date:  2014-12-08       Impact factor: 8.807

4.  Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.

Authors:  T Mark Doherty; Abebech Demissie; Joseph Olobo; Dawit Wolday; Sven Britton; Tewodros Eguale; Pernille Ravn; Peter Andersen
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia.

Authors:  J Vekemans; C Lienhardt; J S Sillah; J G Wheeler; G P Lahai; M T Doherty; T Corrah; P Andersen; K P McAdam; A Marchant
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.

Authors:  Suraj B Sable; Rajnish Kumar; Mamta Kalra; Indu Verma; G K Khuller; Karen Dobos; John T Belisle
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Guinea pig model of Mycobacterium tuberculosis latent/dormant infection.

Authors:  Suely S Kashino; Danielle R Napolitano; Ziedonis Skobe; Antonio Campos-Neto
Journal:  Microbes Infect       Date:  2008-09-06       Impact factor: 2.700

8.  The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10.

Authors:  Richard C Huard; Sadhana Chitale; Mary Leung; Luiz Claudio Oliveira Lazzarini; Hongxia Zhu; Elena Shashkina; Suman Laal; Marcus B Conde; Afrânio L Kritski; John T Belisle; Barry N Kreiswirth; José Roberto Lapa e Silva; John L Ho
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Cell-mediated immune responses of healthy laboratory volunteers to sonicate antigens prepared from the most prevalent strains of Mycobacterium tuberculosis from South India harboring a single copy of IS6110.

Authors:  Priya Rajavelu; Sulochana D Das
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

10.  Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving Toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy.

Authors:  Pablo Schierloh; Noemí Yokobori; Mercedes Alemán; Verónica Landoni; Laura Geffner; Rosa M Musella; Jorge Castagnino; Matias Baldini; Eduardo Abbate; Silvia S de la Barrera; María C Sasiain
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.